Ethylenediamine

Ethylenediamine

SCHEMBL8414481

Cl.Cl.Cl.Cl.NCCN

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115466006-A Soft-shelled turtle culture biological water regulation method 湖南省河洲生态甲鱼养殖有限公司 2022-12-13 CN claimed
WO-2023224097-A1 MEMBRANE-FORMING COMPOSITION, MEMBRANE-LIKE COMPOSITION, AND USE OF SAME 東和薬品株式会社 2023-11-23 WO disclosed
CN-115466006-A Soft-shelled turtle culture biological water regulation method 湖南省河洲生态甲鱼养殖有限公司 2022-12-13 CN disclosed
US-10895522-B2 Particle analysis method for identifying infections SYSMEX CORPORATION (JP) 2021-01-19 US disclosed
EP-3413046-B1 PARTICLE ANALYSIS METHOD, ANALYZER AND COMPUTER PROGRAM FOR IDENTIFYING INFECTIONS SYSMEX CORP (JP) 2020-09-09 EP disclosed
US-20180356328-A1 PARTICLE ANALYSIS METHOD FOR IDENTIFYING INFECTIONS SYSMEX CORPORATION (JP) 2018-12-13 US disclosed
EP-3413046-A1 PARTICLE ANALYSIS METHOD FOR IDENTIFYING INFECTIONS SYSMEX CORPORATION (JP) 2018-12-12 EP disclosed
US-20170247603-A1 METHOD OF TREATING A HYDROCARBON CONTAINING FORMATION SHELL OIL COMPANY 2017-08-31 US disclosed
US-20160177173-A1 METHOD OF TREATING A HYDROCARBON CONTAINING FORMATION SHELL OIL COMPANY 2016-06-23 US disclosed
EP-2399927-A9 NOVEL COMPOUND, PHOSPHORYLATION INHIBITOR, INSULIN RESISTANCE IMPROVING AGENT, AGENT TO PREVENT OR TO TREAT DIABETES, AND SCREENING METHOD Fujitsu Limited (JP) 2012-06-13 EP disclosed
EP-2399927-A1 NOVEL COMPOUND, PHOSPHORYLATION INHIBITOR, INSULIN RESISTANCE IMPROVING AGENT, AGENT TO PREVENT OR TO TREAT DIABETES, AND SCREENING METHOD Fujitsu Limited (JP) 2011-12-28 EP disclosed
EP-0611792-B1 Graft polymerization MEDTRONIC INC (US) 1999-08-11 EP disclosed
EP-0611792-A1 Graft polymerization MEDTRONIC, INC. (US) 1994-08-24 EP disclosed
US-5229172-A Irradiation in presenc of oxygen, grafting with acrylamide mon monomer in presence of ceric ion MEDTRONIC, INC. (US) 1993-07-20 US disclosed
US-4214978-A FLUIDIZED BED REGENERATION OF ZEOLITE CATALYST USING PLATINUM COMPOUND-IMPREGNATED CALCINED KAOLIN MICROSPHERES AS PROMOTER ENGELHARD MINERALS & CHEMICALS CORPORATION (US) 1980-07-29 US disclosed
US-4171286-A CLACINED KAOLIN CLAY IMPREGNATED WITH A PLATINUM COMPOUND ENGELHARD MINERALS & CHEMICALS CORPORATION (US) 1979-10-16 US disclosed
US-4010200-A FOR DYEING LIVE HUMAN HAIR SOCIETE ANONYME DITE: L'OREAL (FR) 1977-03-01 US disclosed